Effect of intermittent fasting on sciatic neurofilaments in acrylamide administered rats

Acrylamide is a widely used chemical in industrial manufacturing and laboratory studies. Long term use of this chemical causes axonal degeneration. In this study, 20 mg/kg of acrylamide was administered to Wistar-albino rats daily and effects on sciatic nerve and any potential protective activity of intermittent fasting were investigated. Effect of acrylamide and intermittent fasting was assessed by immunefluorescent method. As a result paralysis in hind legs and coordination problems during walking was observed in acrylamide administered group. These problems were less frequent in intermittent fasting group. In addition, a decrease in neurofilament number was observed in acrylamide group whereas neurofilament level was similar with control group in intermittent fasting group. Concomitant administration of acrylamide and intermittent fasting caused ameliorating effect of intermittent fasting. A potential protective effect of intermittent fasting against acrylamide can be considered according to such results.

___

Stone JD, Peterson AP, Eyer J, Oblak TG, Sickles DW. Neurofilaments are nonessential to the pathogenesis of toxicant-induced axonal degeneration. Journal of Neuroscience 2001; 21: 2278-2287.

LoPachin RM, Balaban CD, Ross JF. Acrylamide axonopathy revisited. Toxicology and Applied Pharmacology 2003; 188:135–153.

Yu S, Son F, Yu J, Zhao X, Yu L, Li G, Xie K. Acrylamide alters cytoskeletal protein level in rat sciatic nerves. Neurochemical Research 2006; 31: 1197-1204.

Tikoo K, Tripathi DN, Kabra DG, Sharma V, Gaikwad AB. Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53. FEBS Letters 2007; 581: 1071-1078.

Jeong MA, Plunet W, Streijger F, Lee JH, Plemel JR, Park S, Tetzlaff W. Intermittent fasting improves functional recovery after rat thoracic contusion spinal cord injury. Journal of Neurotrauma 2011; 28: 479-492.

Opalach K, Rangaraju S, Madorsky I, Leeuwenburgh C, Notterpek L. Lifelong calorie restriction alleviates age-related oxidative damage in peripheral nerves. Rejuvenation Research 2010; 13: 65-74.

Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Metabolism 2014; 19: 181-192.

Rocha NS, Barbisan LF, de Oliveira MLC, de Camargo JLV. Effects of fasting and intermittent fasting on rat hepatocarcinogenesis induced by diethylnitrosamine. Teratogenesis, Carcinogenesis, and Mutagenesis 2002; 22: 129-138.

Ahmet I, Wan R, Mattson MP, Lakatta EG, Talan M. Cardioprotection by intermittent fasting in rats. Circulation 2005; 112: 3115-3121.

Mattsson N, Andreasson U, Zetterberg H, Blennow K. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. Jama Neurology 2017; 74: 557- 566.

Liu Q, Xie F, Siedlak SL, Nunomura A, Honda K, Moreira PI, Perry G. Neurofilament proteins in neurodegenerative diseases. Cellular and Molecular Life Sciences 2004; 61: 3057-3075.

Lin WW, Friedman MA, Wang XF, Abou-Donia MB. Acrylamide-regulated neurofilament expression in rat pheochromocytoma cells. Brain Research 2000; 852: 297-304.

Endo H, Kittur S, Sabri MI. Acrylamide alters neurofilament protein gene expression in rat brain. Neurochemical Research 1994; 19: 815-820.

Takahashi A, Mizutani M, Itakura C. Acrylamideinduced peripheral neuropathy in normal and neurofilament-deficient Japanese quails. Acta Neuropathologica 1995; 89: 17-22.

Suzuki K, Pfaff LD. Acrylamide neuropathy in rats. Acta Neuropathologica 1973; 24: 197-213.

LoPachin RM. The changing view of acrylamide neurotoxicity. Neurotoxicology 2004; 25: 617-630.

Dybing E, Farmer PB, Andersen M, Fennell TR, Lalljie SPD, Müller DJG, Scimeca J. A. Human exposure and internal dose assessments of acrylamide in food. Food and Chemical Toxicology 2005; 43: 365-410.